Do you want to read an article? Please log in or register.
The Treatment of Inflammatory Bowel Disease in Patients With a History of Malignancy
Inflammatory Bowel Disease
Related content
Inflammatory Bowel Disease
Treatment of Inflammatory Bowel Disease in the Older Patient
Inflamm Bowel Dis.
Dorreen A, Heisler C, Jones J
doi: 10.1093/ibd/izy023.
Inflammatory Bowel Disease
Metronidazole or Rifaximin for Treatment of Clostridium difficile in Pediatric Patients with Inflammatory Bowel Disease: A Randomized Clinical Trial
Inflamm Bowel Dis.
Gawronska A, Banasiuk M, Lachowicz D, Pituch H, Albrecht P, Banaszkiewicz A
doi: 10.1097/
Inflammatory Bowel Disease
Illness Perception in Inflammatory Bowel Disease Patients is Different Between Patients With Active Disease or in Remission: A Prospective Cohort Study
doi: 10.1093/ecco-jcc/jjy183.
Inflammatory Bowel Disease
Change of treatment modalities over the last 10 years in pediatric patients with inflammatory bowel disease in Switzerland
Eur J Gastroenterol Hepatol.
Guilcher K, Fournier N, Schoepfer A, Schibli S, Spalinger J, Braegger C, Nydegger A; Swiss IBD Cohort Study
doi: 10.1097/
Inflammatory Bowel Disease
Real-world Pattern of Biologic Use in Patients With Inflammatory Bowel Disease: Treatment Persistence, Switching, and Importance of Concurrent Immunosuppressive Therapy
Inflamm Bowel Dis.
Chen C, Hartzema AG, Xiao H, Wei YJ, Chaudhry N, Ewelukwa O, Glover SC, Zimmermann EM
doi: 10.1093/ibd/izz001.
RECOMMENDED
Inflammatory Bowel Disease
Predicting, Preventing, and Managing Treatment-related Complications in Patients With Inflammatory Bowel Diseases
★ 3
Recommended by
Prof. Dr Stephan Vavricka, Faculty Member
Clin Gastroenterol Hepatol.
Beaugerie L, Rahier JF, Kirchgesner J
doi: 10.1016/j.cgh.2020.02.009.
Inflammatory Bowel Disease
Impact of COVID-19 pandemic on the daily management of biotechnological therapy in inflammatory bowel disease patients: Reorganisational response in a high-volume Italian inflammatory bowel disease centre
United European Gastroenterol J.
Scaldaferri F, Pugliese D, Privitera G, Onali S, Lopetuso LR, Rizzatti G, Settanni CR, Pizzoferrato M, Schiavoni E, Turchini L, Amatucci V, Napolitano D, Bernabei T, Mora V, Laterza L, Papa A, Guidi L, Rapaccini GL, Gasbarrini A, Armuzzi A
doi: 10.1177/2050640620929133.
Inflammatory Bowel Disease
Effect of distance to specialist care for the diagnosis and disease outcome of inflammatory bowel disease in the Swiss inflammatory bowel disease cohort study
Therap Adv Gastroenterol.
Grob L, Bluemel S, Biedermann L, Fournier N, Rossel JB, Vavricka SR, Zeitz J, Rogler G, Stallmach A, Scharl M
doi: 10.1177/1756284819895217.
Inflammatory Bowel Disease
Pre-treatment Frailty Is Independently Associated With Increased Risk of Infections After Immunosuppression in Patients with Inflammatory Bowel Diseases
Gastroenterology.
Kochar B, Cai W, Cagan A, Ananthakrishnan AN
doi: 10.1053/j.gastro.2020.02.032.